← Active opportunities
OpenCombined Synopsis/Solicitation

6505--FDG Radiopharmaceutical

Solicitation number36C24426Q0900

VETERANS AFFAIRS, DEPARTMENT OF · VETERANS AFFAIRS, DEPARTMENT OF · 244-NETWORK CONTRACT OFFICE 4 (36C244)

View opportunity on SAM.gov ↗
Response deadlineSep 17, 2026, 10:00 AM UTC
Deadline status14 days remaining
PostedSep 1, 2026
Record refreshedSep 2, 2026
Place of performanceDepartment of Veterans Affairs Philadelphia VA Medical Center 3900 Woodland Ave, Philadelphia, 19106, United States

Opportunity summary

Source-cited

The Veterans Affairs is requesting quotations for Fluorodeoxyglucose (FDG) radiopharmaceuticals for delivery to the Philadelphia VA Medical Center. The response deadline for this commercial item solicitation is September 17, 2026. [2]

Key points

  • Acquisition is for FDG radiopharmaceuticals. [2]
  • Performance location is Philadelphia VA Medical Center. [2]

Watch items

  • Response due date is September 17, 2026. [2]
  • Evaluation does not individually assess quotes. [1]

Sources

  1. 36C24426Q0900_1.docxIt does not individually evaluate quote/offers against specified evaluation factors.
  2. Official SAM.gov noticePlace of performance: Department of Veterans Affairs Philadelphia VA Medical Center 3900 Woodland Ave, Philadelphia, 19106, USA

Generated from the public notice and source-backed solicitation passages. Confirm important requirements in the cited brief and official documents.

Public-source intelligence

Source-backed opportunity brief

7 citations · 6 sources

See sections 1823 through 1825 and 1832 of Public Law 118-31 for statutory requirements pertaining to exemptions, exceptions, and waivers. (d) *Prohibition on using or providing specific products or services or conducting certain transactions regardless of connection to contract*. (1) *Certain telecommunications and video surveillance equipment, systems, or services*. (i) Unless an applicable waiver has been issued by the Government, the Contractor cannot use any equipment, systems, or services that uses covered telecommunications equipment or services as a substantial or essential component of any system, or as critical technology as part of any system (paragraph (a)(1)(B) of section 889 of the John S.

Scope

(viii) If the product or service is related to item maintenance, include the following information on the item being maintained: (A) Brand; (B) Model number, OEM number, manufacturer part number, or wholesaler number; and (C) Item description, as applicable. (ix) Any readily available information about mitigation actions implemented or recommended. (2) If a report must be submitted to a contracting office, the Contractor shall submit the report as follows: (i) If a Department of Defense contracting office, the Contractor shall report to the website at [*https://dibnet.dod.mil*](https://dibnet.dod.mil). (ii) For all other contracting offices, the Contractor shall report to the Contracting Officer. (iii) For indefinite delivery contracts, the Contractor shall report to both the contracting office for the indefinite delivery contract and the contracting office for any affected order. (3) If the report provided does not contain any of the information required by paragraph (h)(1) of this clause, and the contractor later discovers new information that is required by paragraph (h)(1) of this clause, then the contractor shall submit a subsequent report within 72 hours of discovering the new information. (4) The contractor shall also report the information in paragraph (h)(1) if the contractor wishes to ask for a waiver of the requirements of a new FASCSA order being applied through modification. (i) *New FASCSA orders report*. (1) During contract performance, the Contractor shall review SAM at least once every three months, or as advised by the Contracting Officer, to check for covered articles subject to FASCSA order(s), or for products or services produced by a source subject to FASCSA order(s) not currently identified under paragraph (e) of this clause. (2) If the Contractor identifies a new FASCSA order(s) that could impact their supply chain, then the Contractor shall conduct a reasonable inquiry to identify whether a covered article or product or service produced or provided by a source subject to the FASCSA order(s) was provided to the Government or used during contract performance.

Deliverables

For Federal Supply Schedules, Governmentwide acquisition contracts, multi-agency contracts or any other procurement instrument intended for use by multiple agencies, upon notification from the Contracting Officer, during the performance of the contract, the Contractor shall promptly make any necessary changes or modifications to remove any product or service produced or provided by a source that this clause prohibits. (h) *General report*. (1) If the Contractor identifies or is notified by any source, (including a subcontractor at any tier), that any product or service provided or used (or to be provided or used) during contract performance does not comply with any prohibition in this clause, then the Contractor shall report the following information, or as much information is known, in writing to the contracting office as identified in paragraph (h)(2) within 72 hours: (i) Contract number and order number, if applicable; (ii) The specific prohibition the product or service is not complying with; (iii) A description of the products or services that the Contractor identifies or has reason to suspect is prohibited (include brand; model number, such as the original equipment manufacturer (OEM) number, manufacturer part number, or wholesaler number; and item description, as applicable); (iv) The entity that produced the product or service (include entity name, unique entity identifier, Contractor and Government Entity (CAGE) code, facilities responsible for design, fabrication, assembly, packaging, and test of the product, and whether the entity was the OEM or a distributor (provide manufacturer codes and distributor codes used for the product)); (v) Description of the functionality of the product or service and how that functionality impacts the risk to the product or service; (vi) An explanation of any factors relevant to determining if the product or service should be permitted by an applicable exception, exemption, or waiver (if the contractor would like the Government to consider a waiver, and asks for such a waiver); (vii) Whether alternative products or services are available that would comply with the prohibition; (viii) If the product or service is related to item maintenance, include the following information on the item being maintained: (A) Brand; (B) Model number, OEM number, manufacturer part number, or wholesaler number; and (C) Item description, as applicable. (ix) Any readily available information about mitigation actions implemented or recommended. (2) If a report must be submitted to a contracting office, the Contractor shall submit the report as follows:

Submission

Quoters advised to follow and submit requirements stated in section E.2 Addendum to FAR 52.212-1 Instructions to Offerors when submitting quote.

Place of performance

Department of Veterans Affairs Philadelphia VA Medical Center 3900 Woodland Ave, Philadelphia, 19106, USA

Extracted from the official notice and archived solicitation files. Confirm controlling requirements in the source documents.

Notice information

Read full notice text

COMBINED SYNOPSIS/SOLICITATION FOR COMMERCIAL ITEMS General Information Document Type Combined Solicitation/Synopsis Solicitation Number 36C24426Q0900 Posted Date 09/01/2026 Response Due Date 09/17/2026 at 6:00am ET Product or Service Code 6505 Set Aside No set-aside NAICS Code 325412 Contracting Office Address 1010 Delafield Rd, Pittsburgh PA 15215 Description This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. Solicitation number 36C24426Q0900 is issued as a request for quotation (RFQ) for Fluorodeoxyglucose (FDG) radiopharmaceuticals. This acquisition is not set-aside for small business concerns. This incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. The Pittsburgh, PA Contracting Office is seeking a supplier for Fluorodeoxyglucose (FDG) radiopharmaceuticals delivered to the Philadelphia VA Medical Center located at 3900 Woodland Avenue, Philadelphia, PA 19104. The Statement of Need (SON) is provided. Service Contract Act Wage Determination No. 2015-4235 Rev 27 Dated 07/22/24, applies to this acquisition and will be incorporated into the resulting contract. A copy of the Wage Determination is included with this solicitation as an attachment. The period of performance (POP) is estimated to be 10/14/2026 10/13/2031. Point of Contact Jeff Mann Contract Specialist Commodities 2 (Laboratory and Medical Equipment) Department of Veterans Affairs | Service Area Office East | Network Contracting Office 4 1700 S Lincoln Ave, Lebanon, PA 17042 Jefferson.mann@va.gov

What changed

No field-level changes were detected between related notices.

Notice history

Attachments

Open a filename to view the saved source file. If a saved copy is not available yet, FedRoster will continue to the matching SAM.gov notice.

Back to top ↑